Professional Documents
Culture Documents
Hospital de Especialidades
Centro Mdico Nacional Siglo XXI
Departamento de Reumatologa
Sesin Monogrfica
Dr. Omar Guerrero Soto R3R
Introduccin
Generalidades Manifestaciones Articulares
Mano-Pies Rodillas- Codos Columna Cervical Manifestaciones Extra-articulares. Piel Ojo Hematolgicas Neurolgicas Pulmn Cardiovascular
Artritis Reumatoide.
Crnica inflamatoria sistmica Prevalencia 0.5 2 % Relacin Mujer : Hombre; 2:1 ; 6-8 :1 Incidencia 4ta-5ta dcada de la vida Curso (Progresivo variable) Expectativa Vida ( 4 aos H, 10 aos M ) Mortalidad = enfermedad 3 vasos coronaria
Wong J.B., Ramey D.R., Singh G.: Long-term morbidity, mortality and economics of rheumatoid arthritis. Arthritis Rheum 2001; 44:2746-2749.
Agudo
8-15% das (+, +) Sintomas generales ; Fiebre Actividad ( abrir puerta, jugar Golf) Asimtrico Intermedio :15-20% , Das semanas, Sintomas sistmicos (+)
Aho K., Palosuo T., Raunio V., et al: When does rheumatoid disease start.?. Arthritis Rheum 1985; 28:485-489.
Joint Involvement
MCP, PIP Wrists Knees Shoulders Ankles Feet Elbows Hips Temporomandibular Spine Sternoclavicular Para-articular sites
% Patients (Mean)
91 78 64 65 50 43 38 17 8 4 2 27
% Patients (Range)
74-100 54-82 41-94 33-75 10-67 15-73 13-60 0-40 0-28 0-11 0-6 20-29
Modified from Guerne P-A, Weisman MH: Palindromic rheumatism: Part of or apart from the spectrum of rheumatoid arthritis. Am J Med 16:451-460, 1992. Copyright 1992, with permission from Excerpta Medica, Inc.
73%
Cohorte Olsmted County, MN 609 pacientes Seguimiento 1955-2000 (11.3 aos) Criterios Manifestaciones Extra-Articulares Clnico + Gold Standart
* Descartar otra causa
C. SALVARANI, P. L. MACCHIONI, W. HLA-DRB1 ALLELES ASSOCIATED WITH RHEUMATOID ARTHRITIS IN NORTHERN ITALY: CORRELATION WITH DISEASE SEVERITY. British Journal of Rheumatology 1998;37:165169
Rozin A, Yigla M, Guralnik L. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol. 2006; 25:384388
Sayah A, English JC 3. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol. 2005 Aug;53(2):191-209; quiz 210-2.
Smith JR.Therapy insight : scleritisandits relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol 2007;3(4):21926.
1. AR 18-33%
2. Vasculitis sistmica 7-19% (G.W) 3. LES 4-7% 4. Policondritis Recidivante 3 %
Data from Okhravi N, Odufuwa B, McCluskey P, et al. Scleritis. Surv Ophthalmol 2005; 50(4):35163.
AINES : flurbiprofeno 100 mgs cada 8 horas indometacina 25-50 mgs cada 8 horas.
1.
SmithJ JR. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol 2007;3(4):219.
SmithJR. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol 2007;3(4):21926.
Asocia.
Masculino Ndulos Reumatoides Factor Reumatoide + enf. erosiva. Hipocomplementemia
Mecanismos subyacentes.. Depsitos de complejos inmunes ( IgG, IgM, C3) Anticuerpos antiendotelio 50-60 % Complejo anticuerpos anti-fofatidilserina/protrombina.. ?
Geirsson AJ, Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis. 1987;46(10):727.
1. 2.
Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 1984;76:377-84. Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 1981;43:54-63.
Reporte de Caso / Resolucin de pie pndulo Sin respuesta CFM/esteroide (22 meses) Evento Adverso CFM ( leucopenia + infecciones)
* Dosis 700mgs/semana x 4 semanas (2800mgs) .
Neuropata compresin/atrapamiento ( Subluxacin AAI) Neuropata sensitiva distal Neuropata motor sensitiva
EVC CsCs Encefalopata Meningitis
Tipos.
Anterior ( 50-70% ) Posterior (6.7%) Subaxial vertical ( 4-15%) Lateral < 1 % * Proliferacin sinovial = laxitud roturas ligamentaria
Floyd, A.S.: The cervical spine in rheumatoid arthritis. J. Bone Joint Surg. (Br). 1985; 57: 503.
Anemia NN / Trombocitosis Actividad Enfermedad / VSG Ferritina elevada EPO normal / disminuida INF gamma, IL-1, FNT Causa Mixta ( MTX, AINEs)
Capsoni et al. Primary and secondary autoimmune neutropenia Arthritis Research & Therapy October 2005 Vol 7 No 5,
Clnicamente.
Sntomas Generales 5-10% sin esplenomegalia ; Masiva 1/3 actividad Articular
Ditzel HJ, Masaki Y. Cloning and expression of a novel human antibody-antigen pair associated with Feltys syndrome. Proc Natl Acad Sci USA 2000, 97:9234-9239.
Manifestation Rheumatoid nodules Weight loss Sjgren's syndrome[] Lymphadenopathy Leg ulcers Pleuritis Skin pigmentation Neuropathy Episcleritis
Frequency (%) 76 68 56 34 25 19 17 17 8
Data from Goldberg J, Pinals RS: Felty syndrome. Semin Arthritis Rheum 10:52, 1980.
Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Hellmich B, Schnabel. Poliklinik fr Rheumatologie, Medizinische Universitt zu Lbeck, Germany.
Semin Arthritis Rheum. 1999 Oct;29(2):82-99.
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
Metafratzi ZM. Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 2007;36(5): 33844.
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
EPID asociada AR ; EPI asociada AR, FP y AR. NIU, NINE, NO, BO, Enf. Va area pequea???
+ frecuente manifestacin Pulmonar AR > 5ta dcada > 6 aos de AR ; ( 20 % antes ) Hallazgos pacientes AR / afeccin pulmonar Radiografa PFP/ DLC0 TACAR Trax <5% 33-41 % 20-63 %
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
Incidencia.
o AR 7.7 % Vs 0.9 % poblacin general ; HR 8.8 , IC 95 (4.02-19.94)
Mortalidad. EPID + AR ; HR 2.86 , IC 95 1.98-4.12 Sobrevida media 2.6 aos despus DX.
Clnicamente.
Tos seca; DISNEA,,,,,,COR-PULMONALE PFR DLCO disminuida < 50 %, Restrictivo pulmonar
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
NIU NINE NO
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
Tratamiento. NIU , NO ( esteroides + inmunosupresores ) + ATB Enf. Va area pequea mal pronstico
Danielle. Clin Pulmonary Manifestations of Rheumatoid Arthritis. Chest Med 31 (2010) 451478
Vassallo R, Matteson E, Thomas CF Jr. Clinical response of rheumatoid arthritisassociated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Chest 2002;122(3):10936.
Rheumatology 2006;45:iv4iv7
Pericarditis. + frecuente ECOcardiograma/ postmorten 30-50% < 10 % sntomas Factores Manifestaciones Extra. Tratamiento. AINEs- Esteroides Pericardiocentesis toma , Ventana pericardica
Guedes C, Bianchi-Fior P, Cormier B, Barthelemy B, Rat AC, Boissier MC. Cardiac manifestations of rheumatoid arthritis: a case- control transoesophageal echocardiography study in 30 patients. Arthritis Rheum 2001;45:12935.
20 % post-morten Dx. Biopsia Tx. Inmunosupresor. 30-80% Mitral 9-33% tricuspdea * ndulos
Valvulopata
Guedes C, Bianchi-Fior P, Cormier B, Barthelemy B, Rat AC, Boissier MC. Cardiac manifestations of rheumatoid arthritis: a case- control transoesophageal echocardiography study in 30 patients. Arthritis Rheum 2001;45:12935.
Riesgo Cardiovascular AR ( VSG >60 , > 3 determinaciones) HR 2.03 IC 95 % 1.45-2.83 Excluyendo los factores de riesgo independientes tradicionales
Peter Paul Rubens / Alemania Naci 28/ julio /1577- 30/ Mayo 1640 Pintor barroco de la escuela flamenca Enfatizaba el movimiento , color y la sensualidad. Coleccin Mayor Museo del Prado Galera nacional de Londres.